{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:33:28Z","timestamp":1791747208119,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,3,1]],"date-time":"2009-03-01T00:00:00Z","timestamp":1235865600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"vor","delay-in-days":1598,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1016\/j.ijid.2008.07.006","type":"journal-article","created":{"date-parts":[[2008,10,20]],"date-time":"2008-10-20T04:26:01Z","timestamp":1224476761000},"page":"291-295","source":"Crossref","is-referenced-by-count":9,"title":["Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients"],"prefix":"10.1016","volume":"13","author":[{"given":"Helio S.","family":"Sader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas R.","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald N.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2008.07.006_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.idc.2007.06.005","article-title":"Infections in patients with chronic kidney disease","volume":"21","author":"Foley","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijid.2008.07.006_bib2","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1523-1755.2000.00337.x","article-title":"Mortality caused by sepsis in patients with end-stage renal disease compared with the general population","volume":"58","author":"Sarnak","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijid.2008.07.006_bib3","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/qjmed\/hcm040","article-title":"Vascular access in haemodialysis patients: a modifiable risk factor for bacteraemia and death","volume":"100","author":"Thomson","year":"2007","journal-title":"QJM"},{"key":"10.1016\/j.ijid.2008.07.006_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.7326\/0003-4819-127-4-199708150-00003","article-title":"Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis","volume":"127","author":"Marr","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ijid.2008.07.006_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1111\/j.1523-1755.2005.00414.x","article-title":"Septicemia, access and cardiovascular disease in dialysis patients: the USRDS Wave 2 study","volume":"68","author":"Ishani","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/j.ijid.2008.07.006_bib6","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1001\/jama.297.13.1455","article-title":"Statin use and sepsis events [corrected] in patients with chronic kidney disease","volume":"297","author":"Gupta","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/j.ijid.2008.07.006_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/jhin.2001.1162","article-title":"Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality","volume":"50","author":"Liu","year":"2002","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.ijid.2008.07.006_bib8","first-page":"127","article-title":"Haemodialysis catheter-related bloodstream infections: current treatment options and strategies for prevention","volume":"135","author":"Saxena","year":"2005","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/j.ijid.2008.07.006_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.2165\/00003495-200767100-00008","article-title":"Daptomycin: a review of its use in the management of complicated skin and soft-tissue infections and Staphylococcus aureus bacteraemia","volume":"67","author":"Hair","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.ijid.2008.07.006_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1469-0691.2006.01625.x","article-title":"Test results: characterising the antimicrobial activity of daptomycin","volume":"12","author":"Wiedemann","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2008.07.006_bib11","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1159\/000109868","article-title":"Daptomycin: a review 4 years after first approval","volume":"81","author":"Sauermann","year":"2008","journal-title":"Pharmacology"},{"key":"10.1016\/j.ijid.2008.07.006_bib12","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.diagmicrobio.2006.10.007","article-title":"Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002\u20132005)","volume":"57","author":"Pfaller","year":"2007","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2008.07.006_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.diagmicrobio.2004.07.002","article-title":"Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide","volume":"50","author":"Sader","year":"2004","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijid.2008.07.006_bib14","unstructured":"Package insert. Cubicin (daptomycin for injection). Lexington, MA: Cubist Pharmaceuticals, Inc.; 2006. Available at: http:\/\/www.cubicin.com (accessed October 2008)."},{"key":"10.1016\/j.ijid.2008.07.006_bib15","series-title":"Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard. M7-A7","year":"2006"},{"key":"10.1016\/j.ijid.2008.07.006_bib16","series-title":"Performance standards for antimicrobial susceptibility testing. M100-S17. 17th Informational Supplement","year":"2007"},{"key":"10.1016\/j.ijid.2008.07.006_bib17","first-page":"197","article-title":"Invasive methicillin-resistant Staphylococcus aureus infections among dialysis patients\u2014United States, 2005","volume":"56","year":"2007","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ijid.2008.07.006_bib18","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa043252","article-title":"Methicillin-resistant Staphylococcus aureus disease in three communities","volume":"352","author":"Fridkin","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2008.07.006_bib19","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJM199902183400701","article-title":"Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working Group","volume":"340","author":"Smith","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2008.07.006_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/01.CCM.0000190243.88133.3F","article-title":"Pharmacokinetics and total elimination of meropenem and vancomycin in intensive care unit patients undergoing extended daily dialysis","volume":"34","author":"Kielstein","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ijid.2008.07.006_bib21","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1186\/cc1516","article-title":"Clinical review: use of vancomycin in haemodialysis patients","volume":"6","author":"Launay-Vacher","year":"2002","journal-title":"Crit Care"},{"key":"10.1016\/j.ijid.2008.07.006_bib22","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1128\/AAC.01602-07","article-title":"Larger vancomycin doses (at least four grams per day) are associated with an increased incidence of nephrotoxicity","volume":"52","author":"Lodise","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2008.07.006_bib23","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1128\/AAC.48.8.2799-2807.2004","article-title":"Population pharmacokinetics of daptomycin","volume":"48","author":"Dvorchik","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijid.2008.07.006_bib24","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1093\/jac\/dkm405","article-title":"Elimination of daptomycin in a patient with acute renal failure undergoing extended daily dialysis","volume":"61","author":"Burkhardt","year":"2008","journal-title":"J Antimicrob Chemother"},{"issue":"Suppl 1","key":"10.1016\/j.ijid.2008.07.006_bib25","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.ijantimicag.2007.06.023","article-title":"MRSA bacteraemia","volume":"30","author":"Gould","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijid.2008.07.006_bib26","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1128\/JCM.42.6.2398-2402.2004","article-title":"Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia","volume":"42","author":"Sakoulas","year":"2004","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijid.2008.07.006_bib27","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2008.07.006_bib28","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1093\/ndt\/gfm141","article-title":"In vitro activity of daptomycin and vancomycin lock solutions on staphylococcal biofilms in a central venous catheter model","volume":"22","author":"LaPlante","year":"2007","journal-title":"Nephrol Dial Transplant"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971208014501?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1201971208014501?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,24]],"date-time":"2018-12-24T19:29:31Z","timestamp":1545679771000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1201971208014501"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["S1201971208014501"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2008.07.006","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}